Asedebart may normalize urinary free cortisol in patients with Cushing’s disease

CHICAGO — In a small cohort of patients with Cushing’s disease, most had their urinary free cortisol normalized after being administered asedebart, researchers reported at ENDO 2026.“In Cushing’s disease ... you have a number of hormones that are affected,” Johan Luthman, DDS, PhD, executive vice president and head of research & development at H. Lundbeck, the